Precision Targets for Intercepting the Lethal Progression of Prostate Cancer: Potential Avenues for Personalized Therapy

Precision Targets for Intercepting the Lethal Progression of Prostate Cancer: Potential Avenues for Personalized Therapy

Organ-confined prostate cancer of low-grade histopathology is managed with radiation, surgery, active surveillance, or watchful waiting and exhibits a 5-year overall survival (OS) of 95%, while metastatic prostate cancer (PCa) is incurable, holding a 5-year OS of 30%. Treatment options for advanced...

Full description

Bibliographic Details
Main Authors: Max Christenson, Chung-Seog Song, Ya-Guang Liu, Bandana Chatterjee
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Cancers
Subjects:
high-risk prostate cancer
androgen receptor axis
castration resistance
neuroendocrine carcinoma
PARP inhibition
immunotherapy
Online Access:https://www.mdpi.com/2072-6694/14/4/892

Internet

https://www.mdpi.com/2072-6694/14/4/892

Similar Items